What is NDC 79739-7077?

79739-7077 is the product NDC for Nabumetone 750 mg (nabumetone), Nabumetone 750 mg/1 tablet, film coated, listed with the FDA by LGM PHARMA SOLUTIONS, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Nabumetone 750 mg (Nabumetone).

LGM PHARMA SOLUTIONS, LLC, NDC labeler code 79739. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Nabumetone 750 mg?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Nabumetone 750 mg NDC 79739-7077 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)79739-7077Labeler and product segments. Claims need a package NDC.

Product NDC at billing width79739-7077Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
79739-7077-1	7973970770179739707701	100 TABLET, FILM COATED in 1 BOTTLE (79739-7077-1)Marketed from Sep 4, 2019
79739-7077-5	7973970770579739707705	500 TABLET, FILM COATED in 1 BOTTLE (79739-7077-5)Marketed from Sep 4, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nabumetone 750 mg
Generic name (nonproprietary): nabumetone
Active ingredients: Nabumetone — 750 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: LGM PHARMA SOLUTIONS, LLCNDC labeler code 79739
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203166
Marketing start: Sep 4, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 79739-7077_cf52d275-4853-4576-832a-07630bb644dcSPL ID cf52d275-4853-4576-832a-07630bb644dcSPL set ID ef7c3da8-797f-4ea9-8999-53509785a0f7RxCUI 311892, 311893, 427726UNII LW0TIW155Z
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N479739707701 followed by a unit qualifier and the quantity

Package 79739-7077-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 6, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of nabumetone tablets and other treatment options before deciding to use nabumetone tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see WARNINGS ]. Nabumetone tablets are indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 79739-7077

What is NDC 79739-7077?: 79739-7077 is the product NDC for Nabumetone 750 mg (nabumetone), Nabumetone 750 mg/1 tablet, film coated, listed with the FDA by LGM PHARMA SOLUTIONS, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Nabumetone 750 mg (Nabumetone).
What is the active ingredient?: Nabumetone.
Who is the labeler?: LGM PHARMA SOLUTIONS, LLC, NDC labeler code 79739. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Nabumetone 750 mg?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 203166

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203166
Product	Strength	Form · route	Labeler	Product NDC
Nabumetone 1000 mgnabumetone	Nabumetone 1000 mg/1	Tablet, Film coatedOral	LGM PHARMA SOLUTIONS, LLC	79739-7078
Nabumetone 500 mgnabumetone	Nabumetone 500 mg/1	Tablet, Film coatedOral	LGM PHARMA SOLUTIONS, LLC	79739-7076
Relafen Dsnabumetone	Nabumetone 1000 mg/1	TabletOral	Carwin Pharmaceutical Associates, LLC	15370-170

Nabumetone 750 mg (Nabumetone) NDC 79739-7077